Syed, S.; Hines, J.; Baccile, R.; Rouhani, S.; Reid, P.
Studying Outcomes after Steroid-Sparing Immunosuppressive Agent vs. Steroid-Only Treatment for Immune-Related Adverse Events in Non-Small-Cell Lung Cancer (NSCLC) and Melanoma: A Retrospective Case-Control Study. Cancers 2024, 16, 1892.
https://doi.org/10.3390/cancers16101892
AMA Style
Syed S, Hines J, Baccile R, Rouhani S, Reid P.
Studying Outcomes after Steroid-Sparing Immunosuppressive Agent vs. Steroid-Only Treatment for Immune-Related Adverse Events in Non-Small-Cell Lung Cancer (NSCLC) and Melanoma: A Retrospective Case-Control Study. Cancers. 2024; 16(10):1892.
https://doi.org/10.3390/cancers16101892
Chicago/Turabian Style
Syed, Sharjeel, Jacobi Hines, Rachel Baccile, Sherin Rouhani, and Pankti Reid.
2024. "Studying Outcomes after Steroid-Sparing Immunosuppressive Agent vs. Steroid-Only Treatment for Immune-Related Adverse Events in Non-Small-Cell Lung Cancer (NSCLC) and Melanoma: A Retrospective Case-Control Study" Cancers 16, no. 10: 1892.
https://doi.org/10.3390/cancers16101892
APA Style
Syed, S., Hines, J., Baccile, R., Rouhani, S., & Reid, P.
(2024). Studying Outcomes after Steroid-Sparing Immunosuppressive Agent vs. Steroid-Only Treatment for Immune-Related Adverse Events in Non-Small-Cell Lung Cancer (NSCLC) and Melanoma: A Retrospective Case-Control Study. Cancers, 16(10), 1892.
https://doi.org/10.3390/cancers16101892
